Cover Image
Market Research Report

Global Pneumococcal Conjugate Vaccine (PCV) Industry Research Report, Growth Trends and Competitive Analysis 2020-2026

Published by QYResearch Product code 929370
Published Content info 114 Pages
Delivery time: 2-3 business days
Price
Back to Top
Global Pneumococcal Conjugate Vaccine (PCV) Industry Research Report, Growth Trends and Competitive Analysis 2020-2026
Published: March 24, 2020 Content info: 114 Pages
Description

In 2019, the global Pneumococcal Conjugate Vaccine(PCV) market size was US$ xx million and is forecast to US$ xx million in 2026, growing at a CAGR of xx% during the forecast period. In this study, 2019 has been considered as the base year and 2020 to 2026 as the forecast period to estimate the market size for Pneumococcal Conjugate Vaccine(PCV).

The market research report offered here is a very useful resource that can help manufacturers, stakeholders, decision-makers, and other market participants to become familiar with every factor impacting the growth of the global Pneumococcal Conjugate Vaccine(PCV) market. The analysts authoring the report have closely studied key strategies adopted by top players of the global Pneumococcal Conjugate Vaccine(PCV) market. The report includes SWOT, and other market analyses to provide a clear and deep understanding of important aspects of the global Pneumococcal Conjugate Vaccine(PCV) market. Readers of the report can become informed about current and future trends of the global Pneumococcal Conjugate Vaccine(PCV) market and how they will impact market growth during the forecast period.

Geographic Segmentation

The report offers exhaustive assessment of different region-wise and country-wise Pneumococcal Conjugate Vaccine(PCV) markets such as U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E etc.

For the period 2015-2026, the report provides country-wise revenue and volume sales analysis and region-wise revenue and volume analysis of the global Pneumococcal Conjugate Vaccine(PCV) market. For the period 2015-2020, it provides sales (consumption) analysis and forecast of different regional markets by Application as well as by Type in terms of volume.

Market Segmentation by Type and by Application

The report includes a detailed analysis of leading and by Type and by Application segments of the global Pneumococcal Conjugate Vaccine(PCV) market. All of the segments covered in the report are broadly analyzed based on some deciding factors. The segmental analysis section of the report offers revenue, sales analysis and forecast of the global Pneumococcal Conjugate Vaccine(PCV) market by Type and by Application segment for the period 2015-2026.

Market Segment by Type, the Pneumococcal Conjugate Vaccine(PCV) market is segmented into:

  • PCV13
  • PCV10
  • PCV7

Market Segment by Application, the Pneumococcal Conjugate Vaccine(PCV) market is segmented into:

  • Child
  • Adult

This report includes the following manufacturers; we can also add the other companies as you want.

  • GlaxoSmithKline
  • Pfizer

The study objectives are:

  • To analyze and research the global Pneumococcal Conjugate Vaccine(PCV) status and future forecast, involving capacity, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
  • To present the key Pneumococcal Conjugate Vaccine(PCV) manufacturers, capacity, production, revenue, market share, and recent development for key players.
  • To split the breakdown data by regions, type, companies and applications.
  • To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
  • To identify significant trends, drivers, influence factors in global and regions.
  • To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Pneumococcal Conjugate Vaccine(PCV) are as follows:

  • History Year: 2015-2020
  • Base Year: 2019
  • Estimated Year: 2020
  • Forecast Year 2020 to 2026
Table of Contents

Table of Contents

1. Report Overview

  • 1.1. Research Scope
  • 1.2. Top Pneumococcal Conjugate Vaccine(PCV) Manufacturers Covered: Ranking by Revenue
  • 1.3. Market Segment by Type
    • 1.3.1. Global Pneumococcal Conjugate Vaccine(PCV) Market Size by Type: 2015 VS 2020 VS 2026(US$ Million)
    • 1.3.2. PCV13
    • 1.3.3. PCV10
    • 1.3.4. PCV7
  • 1.4. Market Segment by Application
    • 1.4.1. Global Pneumococcal Conjugate Vaccine(PCV) Consumption by Application: 2015 VS 2020 VS 2026
    • 1.4.2. Child
    • 1.4.3. Adult
  • 1.5. Study Objectives
  • 1.6. Years Considered

2. Global Market Perspective

  • 2.1. Global Pneumococcal Conjugate Vaccine(PCV) Revenue(2015-2026)
    • 2.1.1. Global Pneumococcal Conjugate Vaccine(PCV) Revenue(2015-2026)
    • 2.1.2. Global Pneumococcal Conjugate Vaccine(PCV) Sales(2015-2026)
  • 2.2. Pneumococcal Conjugate Vaccine(PCV) Market Size across Key Geographies Worldwide: 2015 VS 2020 VS 2026
    • 2.2.1. Global Pneumococcal Conjugate Vaccine(PCV) Sales by Regions(2015-2020)
    • 2.2.2. Global Pneumococcal Conjugate Vaccine(PCV) Revenue by Regions(2015-2020)
  • 2.3. Global Top Pneumococcal Conjugate Vaccine(PCV) Regions(Countries) Ranking by Market Size
  • 2.4. Pneumococcal Conjugate Vaccine(PCV) Industry Trends
    • 2.4.1. Pneumococcal Conjugate Vaccine(PCV) Market Top Trends
    • 2.4.2. Market Drivers
    • 2.4.3. Pneumococcal Conjugate Vaccine(PCV) Market Challenges
    • 2.4.4. Porter's Five Forces Analysis
    • 2.4.5. Primary Interviews with Key Pneumococcal Conjugate Vaccine(PCV) Players: Views for Future

3. Competitive Landscape by Manufacturers

  • 3.1. Global Top Pneumococcal Conjugate Vaccine(PCV) Manufacturers by Sales(2015-2020)
    • 3.1.1. Global Pneumococcal Conjugate Vaccine(PCV) Sales by Manufacturers(2015-2020)
    • 3.1.2. Global Pneumococcal Conjugate Vaccine(PCV) Sales Market Share by Manufacturers(2015-2020)
    • 3.1.3. Global 5 and 10 Largest Manufacturers by Pneumococcal Conjugate Vaccine(PCV) Sales in 2019
  • 3.2. Global Top Manufacturers Pneumococcal Conjugate Vaccine(PCV) by Revenue
    • 3.2.1. Global Pneumococcal Conjugate Vaccine(PCV) Revenue by Manufacturers(2015-2020)
    • 3.2.2. Global Pneumococcal Conjugate Vaccine(PCV) Revenue Share by Manufacturers(2015-2020)
    • 3.2.3. Global Pneumococcal Conjugate Vaccine(PCV) Market Concentration Ratio(CR5 and HHI)
  • 3.3. Global Top Manufacturers by Company Type(Tier 1, Tier 2 and Tier 3)(based on the Revenue in Pneumococcal Conjugate Vaccine(PCV) as of 2019)
  • 3.4. Global Pneumococcal Conjugate Vaccine(PCV) Average Selling Price(ASP) by Manufacturers
  • 3.5. Key Manufacturers Pneumococcal Conjugate Vaccine(PCV) Plants/Factories Distribution and Area Served
  • 3.6. Date of Key Manufacturers Enter into Pneumococcal Conjugate Vaccine(PCV) Market
  • 3.7. Key Manufacturers Pneumococcal Conjugate Vaccine(PCV) Product Offered
  • 3.8. Mergers & Acquisitions, Expansion Plans

4. Market Size by Type

  • 4.1. Global Pneumococcal Conjugate Vaccine(PCV) Historic Market Review by Type(2015-2020)
    • 4.1.2. Global Pneumococcal Conjugate Vaccine(PCV) Sales Market Share by Type(2015-2020)
    • 4.1.3. Global Pneumococcal Conjugate Vaccine(PCV) Revenue Market Share by Type(2015-2020)
    • 4.1.4. Pneumococcal Conjugate Vaccine(PCV) Price by Type(2015-2020)
  • 4.1. Global Pneumococcal Conjugate Vaccine(PCV) Market Estimates and Forecasts by Type(2021-2026)
    • 4.2.2. Global Pneumococcal Conjugate Vaccine(PCV) Sales Forecast by Type(2021-2026)
    • 4.2.3. Global Pneumococcal Conjugate Vaccine(PCV) Revenue Forecast by Type(2021-2026)
    • 4.2.4. Pneumococcal Conjugate Vaccine(PCV) Price Forecast by Type(2021-2026)

5. Global Pneumococcal Conjugate Vaccine(PCV) Market Size by Application

  • 5.1. Global Pneumococcal Conjugate Vaccine(PCV) Historic Market Review by Application(2015-2020)
    • 5.1.2. Global Pneumococcal Conjugate Vaccine(PCV) Sales Market Share by Application(2015-2020)
    • 5.1.3. Global Pneumococcal Conjugate Vaccine(PCV) Revenue Market Share by Application(2015-2020)
    • 5.1.4. Pneumococcal Conjugate Vaccine(PCV) Price by Application(2015-2020)
  • 5.2. Global Pneumococcal Conjugate Vaccine(PCV) Market Estimates and Forecasts by Application(2021-2026)
    • 5.2.2. Global Pneumococcal Conjugate Vaccine(PCV) Sales Forecast by Application(2021-2026)
    • 5.2.3. Global Pneumococcal Conjugate Vaccine(PCV) Revenue Forecast by Application(2021-2026)
    • 5.2.4. Pneumococcal Conjugate Vaccine(PCV) Price Forecast by Application(2021-2026)

6. North America

  • 6.1. North America Pneumococcal Conjugate Vaccine(PCV) Breakdown Data by Company
  • 6.2. North America Pneumococcal Conjugate Vaccine(PCV) Breakdown Data by Type
  • 6.3. North America Pneumococcal Conjugate Vaccine(PCV) Breakdown Data by Application
  • 6.4. North America Pneumococcal Conjugate Vaccine(PCV) Breakdown Data by Countries
    • 6.4.1. North America Pneumococcal Conjugate Vaccine(PCV) Sales by Countries
    • 6.4.2. North America Pneumococcal Conjugate Vaccine(PCV) Revenue by Countries
    • 6.4.3. U.S.
    • 6.4.4. Canada

7. Europe

  • 7.1. Europe Pneumococcal Conjugate Vaccine(PCV) Breakdown Data by Company
  • 7.2. Europe Pneumococcal Conjugate Vaccine(PCV) Breakdown Data by Type
  • 7.3. Europe Pneumococcal Conjugate Vaccine(PCV) Breakdown Data by Application
  • 7.4. Europe Pneumococcal Conjugate Vaccine(PCV) Breakdown Data by Countries
    • 7.4.1. Europe Pneumococcal Conjugate Vaccine(PCV) Sales by Countries
    • 7.4.2. Europe Pneumococcal Conjugate Vaccine(PCV) Revenue by Countries
    • 7.4.3. Germany
    • 7.4.4. France
    • 7.4.5. U.K.
    • 7.4.6. Italy
    • 7.4.7. Russia

8. Asia Pacific

  • 8.1. Asia Pacific Pneumococcal Conjugate Vaccine(PCV) Breakdown Data by Company
  • 8.2. Asia Pacific Pneumococcal Conjugate Vaccine(PCV) Breakdown Data by Type
  • 8.3. Asia Pacific Pneumococcal Conjugate Vaccine(PCV) Breakdown Data by Application
  • 8.4. Asia Pacific Pneumococcal Conjugate Vaccine(PCV) Breakdown Data by Regions
    • 8.4.1. Asia Pacific Pneumococcal Conjugate Vaccine(PCV) Sales by Regions
    • 8.4.2. Asia Pacific Pneumococcal Conjugate Vaccine(PCV) Revenue by Regions
    • 8.4.3. China
    • 8.4.4. Japan
    • 8.4.5. South Korea
    • 8.4.6. India
    • 8.4.7. Australia
    • 8.4.8. Taiwan
    • 8.4.9. Indonesia
    • 8.4.10. Thailand
    • 8.4.11. Malaysia
    • 8.4.12. Philippines
    • 8.4.13. Vietnam

9. Latin America

  • 9.1. Latin America Pneumococcal Conjugate Vaccine(PCV) Breakdown Data by Company
  • 9.2. Latin America Pneumococcal Conjugate Vaccine(PCV) Breakdown Data by Type
  • 9.3. Latin America Pneumococcal Conjugate Vaccine(PCV) Breakdown Data by Application
  • 9.4. Latin America Pneumococcal Conjugate Vaccine(PCV) Breakdown Data by Countries
    • 9.4.1. Latin America Pneumococcal Conjugate Vaccine(PCV) Sales by Countries
    • 9.4.2. Latin America Pneumococcal Conjugate Vaccine(PCV) Revenue by Countries
    • 9.4.3. Mexico
    • 9.4.4. Brazil
    • 9.4.5. Argentina

10. Middle East and Africa

  • 10.1. Middle East and Africa Pneumococcal Conjugate Vaccine(PCV) Breakdown Data by Type
  • 10.2. Middle East and Africa Pneumococcal Conjugate Vaccine(PCV) Breakdown Data by Application
  • 10.3. Middle East and Africa Pneumococcal Conjugate Vaccine(PCV) Breakdown Data by Countries
    • 10.3.1. Middle East and Africa Pneumococcal Conjugate Vaccine(PCV) Sales by Countries
    • 10.3.2. Middle East and Africa Pneumococcal Conjugate Vaccine(PCV) Revenue by Countries
    • 10.3.3. Turkey
    • 10.3.4. Saudi Arabia
    • 10.3.5. U.A.E

11. Company Profiles

  • 11.1. GlaxoSmithKline
    • 11.1.1. GlaxoSmithKline Corporation Information
    • 11.1.2. GlaxoSmithKline Business Overview and Total Revenue(2019 VS 2018)
    • 11.1.3. GlaxoSmithKline Pneumococcal Conjugate Vaccine(PCV) Sales, Revenue, Average Selling Price(ASP) and Gross Margin(2015-2020)
    • 11.1.4. GlaxoSmithKline Pneumococcal Conjugate Vaccine(PCV) Products and Services
    • 11.1.5. GlaxoSmithKline SWOT Analysis
    • 11.1.6. GlaxoSmithKline Recent Developments
  • 11.2. Pfizer
    • 11.2.1. Pfizer Corporation Information
    • 11.2.2. Pfizer Business Overview and Total Revenue(2019 VS 2018)
    • 11.2.3. Pfizer Pneumococcal Conjugate Vaccine(PCV) Sales, Revenue, Average Selling Price(ASP) and Gross Margin(2015-2020)
    • 11.2.4. Pfizer Pneumococcal Conjugate Vaccine(PCV) Products and Services
    • 11.2.5. Pfizer SWOT Analysis
    • 11.2.6. Pfizer Recent Developments

12. Supply Chain and Sales Channels Analysis

  • 12.1. Supply Chain Analysis
  • 12.2. Sales Channels Analysis
    • 12.2.1. Pneumococcal Conjugate Vaccine(PCV) Sales Channels
    • 12.2.2. Pneumococcal Conjugate Vaccine(PCV) Distributors
  • 12.3. Pneumococcal Conjugate Vaccine(PCV) Customers

13. Estimates and Projections by Regions(2021-2026)

  • 13.1. Global Pneumococcal Conjugate Vaccine(PCV) Sales Forecast(2021-2026)
    • 13.1.1. Global Pneumococcal Conjugate Vaccine(PCV) Sales Forecast by Regions(2021-2026)
    • 13.1.2. Global Pneumococcal Conjugate Vaccine(PCV) Revenue Forecast by Regions(2021-2026)
  • 13.2. North America Market Size Forecast(2021-2026)
    • 13.2.1. North America Pneumococcal Conjugate Vaccine(PCV) Sales Forecast(2021-2026)
    • 13.2.2. North America Pneumococcal Conjugate Vaccine(PCV) Revenue Forecast(2021-2026)
    • 13.2.3. North America Pneumococcal Conjugate Vaccine(PCV) Size Forecast by County(2021-2026)
  • 13.3. Europe Market Size Forecast(2021-2026)
    • 13.3.1. Europe Pneumococcal Conjugate Vaccine(PCV) Sales Forecast(2021-2026)
    • 13.3.2. Europe Pneumococcal Conjugate Vaccine(PCV) Revenue Forecast(2021-2026)
    • 13.3.3. Europe Pneumococcal Conjugate Vaccine(PCV) Size Forecast by County(2021-2026)
  • 13.4. Asia Pacific Market Size Forecast(2021-2026)
    • 13.4.1. Asia Pacific Pneumococcal Conjugate Vaccine(PCV) Sales Forecast(2021-2026)
    • 13.4.2. Asia Pacific Pneumococcal Conjugate Vaccine(PCV) Revenue Forecast(2021-2026)
    • 13.4.3. Asia Pacific Pneumococcal Conjugate Vaccine(PCV) Size Forecast by Region(2021-2026)
  • 13.5. Latin America Market Size Forecast(2021-2026)
    • 13.5.1. Latin America Pneumococcal Conjugate Vaccine(PCV) Sales Forecast(2021-2026)
    • 13.5.2. Latin America Pneumococcal Conjugate Vaccine(PCV) Revenue Forecast(2021-2026)
    • 13.5.3. Latin America Pneumococcal Conjugate Vaccine(PCV) Size Forecast by County(2021-2026)
  • 13.6. Middle East and Africa Market Forecast
    • 13.6.1. Middle East and Africa Pneumococcal Conjugate Vaccine(PCV) Sales Forecast(2021-2026)
    • 13.6.2. Middle East and Africa Pneumococcal Conjugate Vaccine(PCV) Revenue Forecast(2021-2026)
    • 13.6.3. Middle East and Africa Pneumococcal Conjugate Vaccine(PCV) Size Forecast by County(2021-2026)

14. Research Findings and Conclusion

15. Appendix

  • 15.1. Research Methodology
    • 15.1.1. Methodology/Research Approach
    • 15.1.2. Data Source
  • 15.2. Author Details
  • 15.3. Disclaimer

List of Tables

  • Table 1. Pneumococcal Conjugate Vaccine(PCV) Key Market Segments
  • Table 2. Ranking of Global Top Pneumococcal Conjugate Vaccine(PCV) Manufacturers by Revenue (US$ Million) in 2019
  • Table 3. Global Pneumococcal Conjugate Vaccine(PCV) Market Size Growth Rate by Type 2021-2026 (K Units) & (Million US$)
  • Table 4. Major Manufacturers of PCV13
  • Table 5. Major Manufacturers of PCV10
  • Table 6. Major Manufacturers of PCV7
  • Table 7. Global Pneumococcal Conjugate Vaccine(PCV) Market Share by Application 2019-2025 (K Units)
  • Table 8. Global Pneumococcal Conjugate Vaccine(PCV) Market Size by Regions 2015-2020 (K Units) & (Million US$)
  • Table 9. Global Pneumococcal Conjugate Vaccine(PCV) Sales by Regions 2015-2020 (K Units)
  • Table 10. Global Pneumococcal Conjugate Vaccine(PCV) Sales Market Share by Regions 2015-2020
  • Table 11. Global Pneumococcal Conjugate Vaccine(PCV) Revenue by Regions 2015-2020 (Million US$)
  • Table 12. Global Pneumococcal Conjugate Vaccine(PCV) Revenue Market Share by Regions 2015-2020
  • Table 13. Top Pneumococcal Conjugate Vaccine(PCV) Regions (Countries) Ranking by Market Size (US$ Million) in 2019
  • Table 14. Market Top Trends
  • Table 15. Pneumococcal Conjugate Vaccine(PCV) Key Drivers: Impact Analysis (2021-2026)
  • Table 16. Pneumococcal Conjugate Vaccine(PCV) Key Challenges
  • Table 17. Main Points Interviewed from Key Pneumococcal Conjugate Vaccine(PCV) Players: Views for Future
  • Table 18. Global Pneumococcal Conjugate Vaccine(PCV) Sales by Manufacturers (2015-2020) (K Units)
  • Table 19. Global Pneumococcal Conjugate Vaccine(PCV) Sales Share by Manufacturers (2015-2020)
  • Table 20. Pneumococcal Conjugate Vaccine(PCV) Revenue by Manufacturers (2015-2020) (Million US$)
  • Table 21. Pneumococcal Conjugate Vaccine(PCV) Revenue Share by Manufacturers (2015-2020)
  • Table 22. Global Pneumococcal Conjugate Vaccine(PCV) Manufacturers Market Concentration Ratio (CR5 and HHI)
  • Table 23. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pneumococcal Conjugate Vaccine(PCV) as of 2019)
  • Table 24. Key Manufacturers Pneumococcal Conjugate Vaccine(PCV) Average Selling Price (ASP) (2015-2020) (US$/Unit)
  • Table 25. Key Manufacturers Pneumococcal Conjugate Vaccine(PCV) Plants/Factories Distribution
  • Table 26. Key Manufacturers Pneumococcal Conjugate Vaccine(PCV) Area Served
  • Table 27. Date of Key Manufacturers Enter into Pneumococcal Conjugate Vaccine(PCV) Market
  • Table 28. Key Manufacturers Pneumococcal Conjugate Vaccine(PCV) Product Type
  • Table 29. Mergers & Acquisitions, Expansion Plans
  • Table 30. Global PCV13 Sales and Revenue (2015-2020) (K Units) & (Million US$)
  • Table 31. Global PCV10 Sales and Revenue (2015-2020) (K Units) & (Million US$)
  • Table 32. Global PCV7 Sales ana Revenue (2015-2020) (K Units) & (Million US$)
  • Table 33. Global Pneumococcal Conjugate Vaccine(PCV) Sales (K Units) by Type (2015-2020)
  • Table 34. Global Pneumococcal Conjugate Vaccine(PCV) Sales Share by Type (2015-2020)
  • Table 35. Global Pneumococcal Conjugate Vaccine(PCV) Revenue (US$ Million) Market Share by Type (2015-2020)
  • Table 36. Global Pneumococcal Conjugate Vaccine(PCV) Price (K Units) by Type (2015-2020)
  • Table 37. Global Pneumococcal Conjugate Vaccine(PCV) Sales (K Units) by Type (2021-2026)
  • Table 38. Global Pneumococcal Conjugate Vaccine(PCV) Sales Share by Type (2021-2026)
  • Table 39. Global Pneumococcal Conjugate Vaccine(PCV) Revenue (US$ Million) Market Share by Type (2021-2026)
  • Table 40. Global Pneumococcal Conjugate Vaccine(PCV) Revenue Share by Type (2021-2026)
  • Table 41. Global Pneumococcal Conjugate Vaccine(PCV) Price (K Units) by Type (2021-2026)
  • Table 42. Global Pneumococcal Conjugate Vaccine(PCV) Sales (K Units) by Application (2015-2020)
  • Table 43. Global Pneumococcal Conjugate Vaccine(PCV) Sales Share by Application (2015-2020)
  • Table 44. Global Pneumococcal Conjugate Vaccine(PCV) Revenue (US$ Million) Market Share by Application (2015-2020)
  • Table 45. Global Pneumococcal Conjugate Vaccine(PCV) Price by Application 2015-2020 (US$/Unit)
  • Table 46. Global Pneumococcal Conjugate Vaccine(PCV) Sales by Application (2015-2020) (K Units)
  • Table 47. Global Pneumococcal Conjugate Vaccine(PCV) Sales Share by Application (2015-2020)
  • Table 48. Global Pneumococcal Conjugate Vaccine(PCV) Revenue (US$ Million) Market Share by Application (2021-2026)
  • Table 49. Global Pneumococcal Conjugate Vaccine(PCV) Revenue Share by Application (2021-2026)
  • Table 50. Global Pneumococcal Conjugate Vaccine(PCV) Price (K Units) by Application (2021-2026)
  • Table 51. North America Pneumococcal Conjugate Vaccine(PCV) Sales by Company (2015-2020) (K Units)
  • Table 52. North America Pneumococcal Conjugate Vaccine(PCV) Sales Market Share by Company (2015-2020)
  • Table 53. North America Pneumococcal Conjugate Vaccine(PCV) Sales by Type (2015-2020) (K Units)
  • Table 54. North America Pneumococcal Conjugate Vaccine(PCV) Sales Market Share by Type (2015-2020)
  • Table 55. North America Pneumococcal Conjugate Vaccine(PCV) Sales by Application (2015-2020) (K Units)
  • Table 56. North America Pneumococcal Conjugate Vaccine(PCV) Sales Market Share by Application (2015-2020)
  • Table 57. North America Pneumococcal Conjugate Vaccine(PCV) Sales by Countries (2015-2020) (K Units)
  • Table 58. North America Pneumococcal Conjugate Vaccine(PCV) Sales Market Share by Countries (2015-2020)
  • Table 59. North America Pneumococcal Conjugate Vaccine(PCV) Revenue by Countries (2015-2020) (Million US$)
  • Table 60. North America Pneumococcal Conjugate Vaccine(PCV) Revenue Market Share by Countries (2015-2020)
  • Table 61. Europe Pneumococcal Conjugate Vaccine(PCV) Sales by Company (2015-2020) (K Units)
  • Table 62. Europe Pneumococcal Conjugate Vaccine(PCV) Sales Market Share by Company (2015-2020)
  • Table 63. Europe Pneumococcal Conjugate Vaccine(PCV) Sales by Type (2015-2020) (K Units)
  • Table 64. Europe Pneumococcal Conjugate Vaccine(PCV) Sales Market Share by Type (2015-2020)
  • Table 65. Europe Pneumococcal Conjugate Vaccine(PCV) Sales by Application (2015-2020) (K Units)
  • Table 66. Europe Pneumococcal Conjugate Vaccine(PCV) Sales Market Share by Application (2015-2020)
  • Table 67. Europe Pneumococcal Conjugate Vaccine(PCV) Sales by Countries (2015-2020) (K Units)
  • Table 68. Europe Pneumococcal Conjugate Vaccine(PCV) Sales Market Share by Countries (2015-2020)
  • Table 69. Europe Pneumococcal Conjugate Vaccine(PCV) Revenue by Countries (2015-2020) (Million US$)
  • Table 70. Europe Pneumococcal Conjugate Vaccine(PCV) Revenue Market Share by Countries (2015-2020)
  • Table 71. Asia Pacific Pneumococcal Conjugate Vaccine(PCV) Sales by Regions (2015-2020) (K Units)
  • Table 72. Asia Pacific Pneumococcal Conjugate Vaccine(PCV) Sales Market Share by Regions (2015-2020)
  • Table 73. Asia Pacific Pneumococcal Conjugate Vaccine(PCV) Sales by Type (2015-2020) (K Units)
  • Table 74. Asia Pacific Pneumococcal Conjugate Vaccine(PCV) Sales Market Share by Type (2015-2020)
  • Table 75. Asia Pacific Pneumococcal Conjugate Vaccine(PCV) Sales by Application (2015-2020) (K Units)
  • Table 76. Asia Pacific Pneumococcal Conjugate Vaccine(PCV) Sales Market Share by Application (2015-2020)
  • Table 77. Asia Pacific Pneumococcal Conjugate Vaccine(PCV) Sales by Countries (2015-2020) (K Units)
  • Table 78. Asia Pacific Pneumococcal Conjugate Vaccine(PCV) Sales Market Share by Regions (2015-2020)
  • Table 79. Asia Pacific Pneumococcal Conjugate Vaccine(PCV) Revenue by Regions (2015-2020) (Million US$)
  • Table 80. Asia Pacific Pneumococcal Conjugate Vaccine(PCV) Revenue Market Share by Regions (2015-2020)
  • Table 81. Latin America Pneumococcal Conjugate Vaccine(PCV) Sales by Company (2015-2020) (K Units)
  • Table 82. Latin America Pneumococcal Conjugate Vaccine(PCV) Sales Market Share by Company (2015-2020)
  • Table 83. Latin America Pneumococcal Conjugate Vaccine(PCV) Sales by Type (2015-2020) (K Units)
  • Table 84. Latin America Pneumococcal Conjugate Vaccine(PCV) Sales Market Share by Type (2015-2020)
  • Table 85. Latin America Pneumococcal Conjugate Vaccine(PCV) Sales by Application (2015-2020) (K Units)
  • Table 86. Latin America Pneumococcal Conjugate Vaccine(PCV) Sales Market Share by Application (2015-2020)
  • Table 87. Latin America Pneumococcal Conjugate Vaccine(PCV) Sales by Countries (2015-2020) (K Units)
  • Table 88. Latin America Pneumococcal Conjugate Vaccine(PCV) Sales Market Share by Countries (2015-2020)
  • Table 89. Latin America Pneumococcal Conjugate Vaccine(PCV) Revenue by Countries (2015-2020) (Million US$)
  • Table 90. Latin America Pneumococcal Conjugate Vaccine(PCV) Revenue Market Share by Countries (2015-2020)
  • Table 91. Middle East and Africa Pneumococcal Conjugate Vaccine(PCV) Sales by Type (2015-2020) (K Units)
  • Table 92. Middle East and Africa Pneumococcal Conjugate Vaccine(PCV) Sales Market Share by Type (2015-2020)
  • Table 93. Middle East and Africa Pneumococcal Conjugate Vaccine(PCV) Sales by Application (2015-2020) (K Units)
  • Table 94. Middle East and Africa Pneumococcal Conjugate Vaccine(PCV) Sales Market Share by Application (2015-2020)
  • Table 95. Middle East and Africa Pneumococcal Conjugate Vaccine(PCV) Sales by Countries (2015-2020) (K Units)
  • Table 96. Middle East and Africa Pneumococcal Conjugate Vaccine(PCV) Sales Market Share by Countries (2015-2020)
  • Table 97. Middle East and Africa Pneumococcal Conjugate Vaccine(PCV) Revenue by Countries (2015-2020) (Million US$)
  • Table 98. Middle East and Africa Pneumococcal Conjugate Vaccine(PCV) Revenue Market Share by Countries (2015-2020)
  • Table 99. GlaxoSmithKline Company Details
  • Table 100. GlaxoSmithKline Description and Business Overview
  • Table 101. GlaxoSmithKline Pneumococcal Conjugate Vaccine(PCV) Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
  • Table 102. GlaxoSmithKline Pneumococcal Conjugate Vaccine(PCV) Sales Growth Rate (2015-2020)
  • Table 103. GlaxoSmithKline Pneumococcal Conjugate Vaccine(PCV) Sales Market Share in Global Market
  • Table 104. GlaxoSmithKline Recent Development
  • Table 105. Pfizer Company Details
  • Table 106. Pfizer Description and Business Overview
  • Table 107. Pfizer Pneumococcal Conjugate Vaccine(PCV) Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
  • Table 108. Pfizer Pneumococcal Conjugate Vaccine(PCV) Sales Growth Rate (2015-2020)
  • Table 109. Pfizer Pneumococcal Conjugate Vaccine(PCV) Sales Market Share in Global Market
  • Table 110. Pfizer Recent Development
  • Table 111. Pneumococcal Conjugate Vaccine(PCV) Distributors List
  • Table 112. Pneumococcal Conjugate Vaccine(PCV) Customers List
  • Table 113. Global Pneumococcal Conjugate Vaccine(PCV) Sales Forecast 2021-2026 (K Units) & (Million US$)
  • Table 114. Global Pneumococcal Conjugate Vaccine(PCV) Sales Forecast by Type 2021-2026 (K Units)
  • Table 115. Global Pneumococcal Conjugate Vaccine(PCV) Sales Forecast by Application 2021-2026 (K Units)
  • Table 116. Global Pneumococcal Conjugate Vaccine(PCV) Sales Forecast by Regions 2021-2026 (K Units)
  • Table 117. Global Pneumococcal Conjugate Vaccine(PCV) Revenue Forecast by Regions 2021-2026 (Million US$)
  • Table 118. North America Pneumococcal Conjugate Vaccine(PCV) Sales Forecast by Countries 2021-2026 (K Units)
  • Table 119. North America Pneumococcal Conjugate Vaccine(PCV) Revenue Forecast by Countries 2021-2026
  • Table 120. Europe Pneumococcal Conjugate Vaccine(PCV) Sales Forecast by Countries 2021-2026 (K Units)
  • Table 121. Europe Pneumococcal Conjugate Vaccine(PCV) Revenue Market Share Forecast by Countries 2021-2026
  • Table 122. Asia Pacific Pneumococcal Conjugate Vaccine(PCV) Sales Forecast by Regions 2021-2026 (K Units)
  • Table 123. Asia Pacific Pneumococcal Conjugate Vaccine(PCV) Revenue Forecast by Regions 2021-2026 (Million US$)
  • Table 124. Latin America Pneumococcal Conjugate Vaccine(PCV) Sales Forecast by Countries 2021-2026 (K Units)
  • Table 125. Latin America Pneumococcal Conjugate Vaccine(PCV) Revenue Forecast by Countries 2021-2026 (Million US$)
  • Table 126. Middle East and Africa Pneumococcal Conjugate Vaccine(PCV) Sales Forecast by Regions 2021-2026 (K Units)
  • Table 127. Middle East and Africa Pneumococcal Conjugate Vaccine(PCV) Revenue Forecast by Regions 2021-2026 (Million US$)
  • Table 128. Research Programs/Design for This Report
  • Table 129. Key Data Information from Secondary Sources
  • Table 130. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Pneumococcal Conjugate Vaccine(PCV) Product Picture
  • Figure 2. Global Pneumococcal Conjugate Vaccine(PCV) Sales Market Shar by Type 2015-2026
  • Figure 3. PCV13 Figures
  • Figure 4. PCV10 Figures
  • Figure 5. PCV7 Figures
  • Figure 6. Global Pneumococcal Conjugate Vaccine(PCV) Sales Market Share by Application in 2019 & 2026
  • Figure 7. Child Use Case
  • Figure 8. Adult Use Case
  • Figure 9. Pneumococcal Conjugate Vaccine(PCV) Report Years Considered
  • Figure 10. Global Pneumococcal Conjugate Vaccine(PCV) Market Size 2015-2026 (Million US$)
  • Figure 11. Global Pneumococcal Conjugate Vaccine(PCV) Sales 2015-2020 (K Units)
  • Figure 12. Global Pneumococcal Conjugate Vaccine(PCV) Market Size Market Share by Regions 2015-2020
  • Figure 13. Global Pneumococcal Conjugate Vaccine(PCV) Sales Market Share by Regions in 2019
  • Figure 14. Porter's Five Forces Analysis
  • Figure 15. Global Pneumococcal Conjugate Vaccine(PCV) Sales Share by Manufacturers in 2019
  • Figure 16. The 5 and 10 Largest Manufacturers in the World: Market Share by Pneumococcal Conjugate Vaccine(PCV) Sales in 2019
  • Figure 17. Pneumococcal Conjugate Vaccine(PCV) Value Share by Manufacturers in 2019
  • Figure 18. Pneumococcal Conjugate Vaccine(PCV) Revenue Share by Manufacturers In 2019
  • Figure 19. Pneumococcal Conjugate Vaccine(PCV) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
  • Figure 20. Global Pneumococcal Conjugate Vaccine(PCV) Revenue Share by Type (2015-2020)
  • Figure 21. Global Pneumococcal Conjugate Vaccine(PCV) Revenue Growth Rate by Type in 2015 & 2019
  • Figure 22. Global Pneumococcal Conjugate Vaccine(PCV) Market Share by Price Range (2015-2020)
  • Figure 23. Global Pneumococcal Conjugate Vaccine(PCV) Revenue Share by Application (2015-2020)
  • Figure 24. Global Pneumococcal Conjugate Vaccine(PCV) Revenue Growth Rate by Application in 2015 & 2019
  • Figure 25. North America Pneumococcal Conjugate Vaccine(PCV) Revenue Growth Rate 2015-2020 (Million US$)
  • Figure 26. U.S. Pneumococcal Conjugate Vaccine(PCV) Sales Growth Rate (2015-2020) (K Units)
  • Figure 27. Canada Pneumococcal Conjugate Vaccine(PCV) Sales Growth Rate (2015-2020) (K Units)
  • Figure 28. Europe Pneumococcal Conjugate Vaccine(PCV) Revenue Growth Rate 2015-2020 (Million US$)
  • Figure 29. Germany Pneumococcal Conjugate Vaccine(PCV) Sales Growth Rate (2015-2020) (K Units)
  • Figure 30. France Pneumococcal Conjugate Vaccine(PCV) Sales Growth Rate (2015-2020) (K Units)
  • Figure 31. U.K. Pneumococcal Conjugate Vaccine(PCV) Sales Growth Rate (2015-2020) (K Units)
  • Figure 32. Italy Pneumococcal Conjugate Vaccine(PCV) Sales Growth Rate (2015-2020) (K Units)
  • Figure 33. Russia Pneumococcal Conjugate Vaccine(PCV) Sales Growth Rate (2015-2020) (K Units)
  • Figure 34. Asia Pacific Pneumococcal Conjugate Vaccine(PCV) Revenue Growth Rate 2015-2020 (Million US$)
  • Figure 35. China Pneumococcal Conjugate Vaccine(PCV) Sales Growth Rate (2015-2020) (K Units)
  • Figure 36. Japan Pneumococcal Conjugate Vaccine(PCV) Sales Growth Rate (2015-2020) (K Units)
  • Figure 37. South Korea Pneumococcal Conjugate Vaccine(PCV) Sales Growth Rate (2015-2020) (K Units)
  • Figure 38. India Pneumococcal Conjugate Vaccine(PCV) Sales Growth Rate (2015-2020) (K Units)
  • Figure 39. Australia Pneumococcal Conjugate Vaccine(PCV) Sales Growth Rate (2015-2020) (K Units)
  • Figure 40. Taiwan Pneumococcal Conjugate Vaccine(PCV) Sales Growth Rate (2015-2020) (K Units)
  • Figure 41. Indonesia Pneumococcal Conjugate Vaccine(PCV) Sales Growth Rate (2015-2020) (K Units)
  • Figure 42. Thailand Pneumococcal Conjugate Vaccine(PCV) Sales Growth Rate (2015-2020) (K Units)
  • Figure 43. Malaysia Pneumococcal Conjugate Vaccine(PCV) Sales Growth Rate (2015-2020) (K Units)
  • Figure 44. Philippines Pneumococcal Conjugate Vaccine(PCV) Sales Growth Rate (2015-2020) (K Units)
  • Figure 45. Vietnam Pneumococcal Conjugate Vaccine(PCV) Sales Growth Rate (2015-2020) (K Units)
  • Figure 46. Latin America Pneumococcal Conjugate Vaccine(PCV) Revenue Growth Rate 2015-2020 (Million US$)
  • Figure 47. Mexico Pneumococcal Conjugate Vaccine(PCV) Sales Growth Rate (2015-2020) (K Units)
  • Figure 48. Brazil Pneumococcal Conjugate Vaccine(PCV) Sales Growth Rate (2015-2020) (K Units)
  • Figure 49. Argentina Pneumococcal Conjugate Vaccine(PCV) Sales Growth Rate (2015-2020) (K Units)
  • Figure 50. Middle East and Africa Pneumococcal Conjugate Vaccine(PCV) Revenue Growth Rate 2015-2020 (Million US$)
  • Figure 51. Turkey Pneumococcal Conjugate Vaccine(PCV) Sales Growth Rate (2015-2020) (K Units)
  • Figure 52. Saudi Arabia Pneumococcal Conjugate Vaccine(PCV) Sales Growth Rate (2015-2020) (K Units)
  • Figure 53. U.A.E Pneumococcal Conjugate Vaccine(PCV) Sales Growth Rate (2015-2020) (K Units)
  • Figure 54. GlaxoSmithKline Total Revenue (US$ Million): 2019 Compared with 2018
  • Figure 55. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
  • Figure 56. Pneumococcal Conjugate Vaccine(PCV) Value Chain
  • Figure 57. Channels of Distribution
  • Figure 58. Distributors Profiles
  • Figure 59. North America Pneumococcal Conjugate Vaccine(PCV) Sales Growth Rate Forecast (2021-2026) (K Units)
  • Figure 60. North America Pneumococcal Conjugate Vaccine(PCV) Revenue Growth Rate Forecast (2021-2026) (US$ Million)
  • Figure 61. Europe Pneumococcal Conjugate Vaccine(PCV) Sales Growth Rate Forecast (2021-2026) (K Units)
  • Figure 62. Europe Pneumococcal Conjugate Vaccine(PCV) Revenue Growth Rate Forecast (2021-2026) (US$ Million)
  • Figure 63. Asia Pacific Pneumococcal Conjugate Vaccine(PCV) Sales Growth Rate Forecast (2021-2026) (K Units)
  • Figure 64. Asia Pacific Pneumococcal Conjugate Vaccine(PCV) Revenue Growth Rate Forecast (2021-2026) (US$ Million)
  • Figure 65. Latin America Pneumococcal Conjugate Vaccine(PCV) Sales Growth Rate Forecast (2021-2026) (K Units)
  • Figure 66. Latin America Pneumococcal Conjugate Vaccine(PCV) Revenue Growth Rate Forecast (2021-2026) (US$ Million)
  • Figure 67. Middle East and Africa Pneumococcal Conjugate Vaccine(PCV) Sales Growth Rate Forecast (2021-2026) (K Units)
  • Figure 68. Middle East and Africa Pneumococcal Conjugate Vaccine(PCV) Revenue Growth Rate Forecast (2021-2026) (US$ Million)
  • Figure 69. Bottom-up and Top-down Approaches for This Report
  • Figure 70. Data Triangulation
  • Figure 71. Key Executives Interviewed
Back to Top